NCT05531968View on ClinicalTrials.gov

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

PHASE3CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

August 10, 2021

Study Completion Date

September 17, 2021

Conditions
Glabellar Lines
Interventions
BIOLOGICAL

BMI2006

IM

BIOLOGICAL

BOTOX®

IM

Trial Locations (3)

06973

Chung-Ang University Hospital, Seoul

05030

Konkuk University Hospital, Seoul

05505

Seoul Asan Medical Center, Seoul

Sponsors

Lead Sponsor

BMI Korea
All Listed Sponsors
lead

BMI Korea

INDUSTRY